article thumbnail

Fireside Chat with Kaitlin Anstett, Senior Medical Advisor at Theratechnologies

Impetus Digital

Kaitlin Anstett Senior Medical Advisor Kaitlin Anstett is currently a Senior Medical Advisor at Theratechnologies, working with their HIV/AIDS portfolio. She graduated from the University of Toronto in 2013, and completed her PhD in Microbiology and Immunology at McGill University in 2017.

Medical 52
article thumbnail

Reducing real world data lag time for improved patient outcomes

Clarivate

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. The suitability of RWD, the FDA said in a 2017 guidance report , depends on its relevance (whether data directly addresses intended use) and reliability (completeness, accuracy and timeliness) [2].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Journal Citation Reports 2022: A preview

Clarivate

For indexing in Web of Science, Early Access is defined as ‘Version of Record’ content that is published online prior to final assignment in a completed volume/issue. The massive and rapid response of the scholarly community to COVID-19 extends far beyond medical care or medical sciences, and its ripples will continue for years, or decades.

article thumbnail

Impact of Marketing Strategies in Healthcare Systems

Medico Reach

However, proper healthcare marketing has made prospects more aware of company insurance and other medical schemes. Although technology and medical sciences have come a long way, marketing healthcare services was difficult until 2017. Importance of Marketing Strategies in Healthcare Systems.

article thumbnail

Recurrent drug shortages signal onerous outlook for cardiovascular care

Pharmaceutical Technology

According to some estimates, between 2017 and 2047, the number of individuals living with stroke will increase by 27% in the EU. Second, adopting a single sourcing strategy creates more risk, explains Liz Breen, PhD, professor at the University of Bradford’s School of Pharmacy and Medical Sciences.

Medicine 111
article thumbnail

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Medgadget

The first human trial done in Israel proved very successful (2017-2018, finalized during COVID), and published in the Red Journal , the official journal of the American Society for Radiation Oncology), involving many patients whose cancer recurred after treatment or whose options were exhausted.